ConductScience.org, home

Paper40237201

Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells.

Lee J and 5 others. FEBS Open Bio, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells. Papers, record 40237201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40237201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells.
PubMed
Journal
FEBS Open Bio
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-07-06
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee JJaehoonhttps://orcid.org/0000-0002-4508-3845
2Koo GBGi-Bang
3Park JJihye
4Han BCByung-Cheol
5Kwon MMijin
6Lee SHSeung-Ho

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EtoposideMajor topic
ApoptosisMajor topic
Tumor Suppressor Protein p53Major topic
Liver NeoplasmsMajor topic
Humans
Hep G2 Cells
N-Acetylglucosaminyltransferases
Down-Regulation
Cell Survival

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R&D Headquarters of Korea Ginseng CorporationPubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122275356Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.J Biol Chem2012https://conductscience.org/library/papers/22275356PubMed
220676906The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways.Amino Acids2011https://conductscience.org/library/papers/20676906PubMed
312615051O-GlcNAc: a regulatory post-translational modification.Biochem Biophys Res Commun2003https://conductscience.org/library/papers/12615051PubMed
430793308Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation.J Cell Physiol2019https://conductscience.org/library/papers/30793308PubMed
517894897Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.Mol Cancer2007https://conductscience.org/library/papers/17894897PubMed
618366759Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity.Mol Cancer2008https://conductscience.org/library/papers/18366759PubMed
730626734Nutrient regulation of signaling and transcription.J Biol Chem2019https://conductscience.org/library/papers/30626734PubMed
830576620Tumor cell escape from therapy-induced senescence.Biochem Pharmacol2019https://conductscience.org/library/papers/30576620PubMed
920940128p53 at a glance.J Cell Sci2010https://conductscience.org/library/papers/20940128PubMed
1035817809Protein O-GlcNAcylation in cardiovascular diseases.Acta Pharmacol Sin2023https://conductscience.org/library/papers/35817809PubMed
1116598783Post-translational modification by O-GlcNAc: another way to change protein function.J Cell Biochem2006https://conductscience.org/library/papers/16598783PubMed
1232851890Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 Cells.Int J Toxicol2020https://conductscience.org/library/papers/32851890PubMed
1327343361O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.J Mol Biol2016https://conductscience.org/library/papers/27343361PubMed
1426600742Molecular mechanisms of etoposide.EXCLI J2015https://conductscience.org/library/papers/26600742PubMed
1534943826Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells.Cells2021https://conductscience.org/library/papers/34943826PubMed
1630824861The multiple mechanisms that regulate p53 activity and cell fate.Nat Rev Mol Cell Biol2019https://conductscience.org/library/papers/30824861PubMed
1719377505DNA topoisomerase II and its growing repertoire of biological functions.Nat Rev Cancer2009https://conductscience.org/library/papers/19377505PubMed
1823914174Mechanisms regulating resistance to inhibitors of topoisomerase II.Front Pharmacol2013https://conductscience.org/library/papers/23914174PubMed
1933121131O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells.Cancers (Basel)2020https://conductscience.org/library/papers/33121131PubMed
2036768465Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD.Int J Mol Sci2023https://conductscience.org/library/papers/36768465PubMed

See all 42 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41939458Regulation of glycosylation in radiotherapy: exploring the multiple effects of DNA damage, immune response, stromal microenvironment and metabolism.Front Oncol2026https://conductscience.org/library/papers/41939458PubMed
41466540Dammarenediol II enhances etoposide-induced apoptosis by targeting O-GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer.Mol Oncol2026https://conductscience.org/library/papers/41466540PubMed
41394960Protein O-GlcNAcylation in Health and Diseases.MedComm (2020)2025https://conductscience.org/library/papers/41394960PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
OGT8473PubTator's text mininghttps://conductscience.org/library/genes/8473NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40237201

GET https://conductscience.org/api/papers/v1/40237201/references?page=2